339 related articles for article (PubMed ID: 29143160)
21. Hybrid imidazole (benzimidazole)/pyridine (quinoline) derivatives and evaluation of their anticancer and antimycobacterial activity.
Mantu D; Antoci V; Moldoveanu C; Zbancioc G; Mangalagiu II
J Enzyme Inhib Med Chem; 2016; 31(sup2):96-103. PubMed ID: 27250919
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, tautomeric structures, and antitumor activity of new perimidines.
Farghaly TA; Mahmoud HK
Arch Pharm (Weinheim); 2013 May; 346(5):392-402. PubMed ID: 23553920
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
[TBL] [Abstract][Full Text] [Related]
24. Antioxidative and antiproliferative activities of novel pyrido[1,2-a]benzimidazoles.
Tireli M; Starčević K; Martinović T; Pavelić SK; Karminski-Zamola G; Hranjec M
Mol Divers; 2017 Feb; 21(1):201-210. PubMed ID: 27677735
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
He J; Wang X; Zhao X; Liang Y; He H; Fu L
Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, anticancer activity and UPLC analysis of the stability of some new benzimidazole-4,7-dione derivatives.
Błaszczak-Swiatkiewicz K; Almeida DC; De Jesus Perry M; Mikiciuk-Olasik E
Molecules; 2013 Dec; 19(1):400-13. PubMed ID: 24384922
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel 2-(2-arylmethylene)hydrazinyl-4-aminoquinazoline derivatives as potent antitumor agents.
Jiang N; Zhai X; Zhao Y; Liu Y; Qi B; Tao H; Gong P
Eur J Med Chem; 2012 Aug; 54():534-41. PubMed ID: 22727449
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential anti-cancer agents.
Alafeefy AM; Ashour AE
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):541-5. PubMed ID: 21851213
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
31. Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met.
Ibrahim HA; Awadallah FM; Refaat HM; Amin KM
Bioorg Chem; 2018 Apr; 77():457-470. PubMed ID: 29453077
[No Abstract] [Full Text] [Related]
32. Synthesis, DNA binding ability and anticancer activity of 2-heteroaryl substituted benzimidazoles linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates.
Kamal A; Pogula PK; Khan MN; Seshadri BN; Sreekanth K
Med Chem; 2013 Aug; 9(5):651-9. PubMed ID: 23301523
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agents.
Abd El-Karim SS; Anwar MM; Zaki ER; Elseginy SA; Nofal ZM
Future Med Chem; 2018 Jan; 10(2):157-181. PubMed ID: 29235906
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and antiproliferative activity of some benzimidazole-4,7-dione derivatives.
Garuti L; Roberti M; Malagoli M; Rossi T; Castelli M
Bioorg Med Chem Lett; 2000 Oct; 10(19):2193-5. PubMed ID: 11012027
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis and in vitro antitumor evaluation of novel pyrazole-benzimidazole derivatives.
Ren B; Liu RC; Ji K; Tang JJ; Gao JM
Bioorg Med Chem Lett; 2021 Jul; 43():128097. PubMed ID: 33979690
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.
Arya S; Kumar N; Roy P; Sondhi SM
Eur J Med Chem; 2013 Jan; 59():7-14. PubMed ID: 23202484
[TBL] [Abstract][Full Text] [Related]
38. Benzimidazole Scaffold as Anticancer Agent: Synthetic Approaches and Structure-Activity Relationship.
Shrivastava N; Naim MJ; Alam MJ; Nawaz F; Ahmed S; Alam O
Arch Pharm (Weinheim); 2017 Jun; 350(6):. PubMed ID: 28544162
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]